Evaluation of liposomal formulations containing the antimalarial agent, arteether

International Journal of Pharmaceutics

Volumn 128, Issue 1-2, 1996, Pages 163-168

  Al Angary, A A ^a   Al Meshal, M A ^a   Bayomi, M A ^a,b   Khidr, S H ^a,c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Al Azhar University   (Egypt)

^c ASSIUT UNIVERSITY   (Egypt)

Author keywords

arteether; liposomal formulation; phospholipid; physico chemical characterization

Indexed keywords

ANTIMALARIAL AGENT; ARTEETHER; DIBEHENOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; LIPOSOME; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; LIPID COMPOSITION; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 0030012086     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04273-3     Document Type: Article

References (17)

1. Akbarieh, N., Besner, T.G., Galal, A. and Tawashi, R., Liposomal delivery system for the targeting and cotrolled release of Praziquatel. Drug Dev. Ind. Pharm., 18 (1992) 303-317.
2. Al-Angary, A.A., Bayomi, M.A., Khidr, S.H., Al-Meshal, M.A. and Lutfi, K.M., Determination of arteether in plasma usig a simple ad rapid HPLC assay. Analyt. Lett., 27(14) (1994) 2689-2702.
3. Al-Angary, A.A., Bayomi, MA., Khidr, S.H., Al-Meshal, M.A. and Al-Dardiri, M., Characterization, stability and in vivo targeting of liposomal formulations containing cyclosporin. Int. J. Pharm., 114 (1995) 221-225.
4. Betageri, G. V. and Burrell, C.S., Stability of antibody-bearing liposomes containing Dioxyinosine Triphosphate. Int. J. Pharm., 98 (1993) 149-155.
5. Brossi, A., Venugopalan, B., Dominguez Gerpe, L., Yeh, H.J.C., Flippen-Anderson, J.L., Buchs, P., Luo, X.D., Milhous, W. and Peters, W., Arteether, a new anti-malarial drug: Synthesis and antimalarial properties. J. Med. Chem., 31 (1988) 645-650.
6. Fielding, M.R., Liposomal drug delivery: Advantages and limitations from a clinical pharmacokinetics and therapeutic perspective. Clin. Pharmacokinet., 21 (1991) 155-164.
7. Gregoriadis, G. and Allison, A.C., Liposomes in Biological System, Chapters 2, 3, 8 and 11, Wiley, New York, 1980.
8. Hwang, K.J., In Liposomes: from Biophysics to Therapeutics, Marcel Dekker Inc., New York, 1987, p. 109.
9. Juliano, R.L. and Daoud, S.A., Liposomes as a delivery system for membrane-active antitumor drugs. J. Controlled Release, II (1990) 225-232.
10. Krishna, K.A. and Flanagan, R.D., Micellar solubilization of a new antimalarial drug, B-Arteether. J. Pharm. Sci., 78(7) (1989) 574-576.
11. Lidgate, D.M., Felgner, P.L. and Fleitman, J.S. Whatley, J. and Fu R.C., In-vitro and in-vivo studies evaluating a liposome system for drug solubilization. Pharm. Res., 5 (1988) 759-764.
12. Lopez-Berestein, G. and Fidler, I.J., Liposomes in the Therapy of Infectious Diseases and Cancer, Alan R. Liss, New York, 1989.
13. Moghimi, S.M., Porter, C.J.H., Illum, L. and Davis, S.S., The effect of poloxamer-407 on liposome stability and targeting to bone marrow: comparison with polystyrene microspheres. Int. J. Pharm., 68 (1991) 121-126.
14. Szoka, F. Jr. and Papahadjopoulos, D., Comparative properties and method of preparation of lipid vesicles (liposomes). Ann. Rev. Biophys. Bioeng., 9 (1980) 467-508.
15. Taylor, K.M.G., Taylor, G., Kellaway, I.W. and Stevens, J., Drug entrapment and release from multilamellar and reverse-phase evaporation liposomes. Int. J. Pharm., 58 (1990) 49-55.
16. Vadiei, K., Loper-Berestein, F., Perez-Sole R. and Luke, R.D., In vitro evaluation of liposomal cyclosporine. Int. J. Pharm., 57 (1989) 133-138.
17. Wu, E.S., Jacobson, K., Szoka, F. and Patis, A., Lateral diffusion of a hydrophobic peptide, N-4-nitrobenz-z-oxa-1,3-diazole Gramicidine s, in phospholipid multibilayers. Biochemistry, 17 (1978) 5543-5550.